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Abstract
Background: Mood disorder after stroke is common but drug and psychosocial treatments have been assessed
with disappointing results. Preventing mood disorder from developing in the first place could be a better approach
and might reduce the need for pharmacotherapy in this predominantly older patient group. We used a brief
problem-solving therapy and evaluated its effect in reducing mood disorder in the 12 months after stroke.
Methods: A 3-group, parallel, randomised controlled trial. Four hundred fifty patients with stroke were randomised
within 1 month of hospital admission to problem-solving therapy from a psychiatric nurse, non-specific support
given by volunteers or treatment-as-usual. Follow up took place at 6 and 12 months after stroke.
Standardised measures of mood (Present State Examination, GHQ-28), cognitive state (mini-mental state
examination) and function (Barthel ADL index, Frenchay Activities Index) were taken at baseline, 6 and 12 months
after randomisation. Satisfaction with care was recorded at follow up.
Results: At 6 months, all psychological and activity measures favoured problem-solving therapy. At 12 months,
patients in the problem-solving therapy group had significantly lower GHQ-28 scores and lower median Present
State Examination symptom scores. There were no statistically significant differences in activity. The problem-solving
therapy group were more satisfied with some aspects of care.
Conclusions: The results are encouraging and suggest it is possible to prevent mood disorder in stroke patients
using a psychological intervention. The differences between the groups at 12 months may indicate a sustained
impact of psychological therapies, by comparison with non-specific support.
Trial registration: ISRCTN: ISRCTN33773710 Registered: 23/01/2004 (Retrospectively).
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Prevention
Background
Stroke patients are a predominantly older group and
around 50% of acute stroke survivors have residual
major physical or cognitive deficits. Given the need for
patients to cope with the complex physical and social se-
quelae of stroke, the demands of recovery and rehabilita-
tion, and the risk of recurrent stroke, it is not surprising
that mood disorder, usually manifesting as anxiety or de-
pression after stroke, is common. The consequences of
unreconciled emotional distress can be reduced quality
of life and impaired progress in physical and social re-
habilitation. A number of drug and psychosocial treat-
ments have been assessed in clinical trials but the results
have been disappointing. Drug trials have suggested a
role for antidepressants in both treatment and preven-
tion, but the trials are generally of poor quality and do
not provide sufficient information to judge their true
costs and benefits [1, 2] Psychosocial interventions have
similar methodological problems [3]. The latter are
popular with patients but there is conflicting evidence
for their effectiveness in either treating or preventing
anxiety and depression [4, 5].
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Nonetheless, psychosocial interventions may have a
role in preventing mood disorder after stroke, as recent
reviews have concluded, and there is still a need for
more trials in this area [6, 7].
Aims and objectives
This study aimed to evaluate the effect of a brief psycho-
logical treatment: problem-solving therapy for reducing
mood disorder in the 12months after stroke [8]. We
used two comparison groups: treatment-as-usual, and an
attention control group that received non-specific sup-
port given by volunteers. Outcomes were measured
quantitatively by a widely-used self-report questionnaire,
the 28-item General Health Questionnaire (GHQ-28) [9]
and by scores derived from a standardised psychiatric
interview the Present State Examination: Short Form
(PSE) [10]. Our secondary hypotheses were that patients
in the problem-solving therapy group would be less
likely to have a diagnosable depressive disorder at follow
up, would have better social function and would be more
satisfied with their care.
Methods
Study design and participants
A 3-group, parallel, randomised controlled trial.
Sample
Patients admitted with first ever or recurrent stroke (di-
agnosed on clinical history and signs, supplemented by
CT brain scan when ordered by clinician) to hospitals in
Leeds and Bradford. We were notified of stroke admis-
sions in the two Leeds trusts by the Leeds Stroke Data-
base. In Bradford we contacted admitting wards each
week.
Inclusion criteria
Adults admitted to hospital with first ever or recurrent
stroke (other than subarachnoid haemorrhage) within
the past month; who were local residents and able to
give written consent.
Exclusion criteria
Patients who were: too ill to interview within 1month of
stroke; unable to participate through impaired speech,
cognition or use of English; living in a residential home;
had a serious concurrent illness, which was likely to
dominate the pattern of care or were participating in an-
other rehabilitation trial.
Randomisation and masking
The trial had three arms: problem-solving therapy from
a psychiatric nurse, non-specific support given by volun-
teers or treatment-as-usual. We screened all notifica-
tions of stroke admissions, and after obtaining verbal
consent for the initial assessment we undertook a base-
line interview and a Mini-Mental State Examination
(MMSE) [11]. Randomisation was third party, after a
telephone call from a research interviewer to a remote
trials office. Random allocation was generated by com-
puter in the trials office in blocks of 15, stratified by ad-
mitting NHS trusts. Eligible patients were then asked to
give written consent to the treatment to which they had
been randomised, and to be followed up at 6 and 12
months. If the patient refused the intervention we asked
them to consent to follow-up. Patients were sent a letter
confirming their participation and giving the name of
their volunteer or nurse, as appropriate, and the planned
follow-up dates. In this way, patients were not aware
that their treatment was being randomly allocated, and
did not know that other patients were receiving a differ-
ent treatment. This design, which is a variant of Zelen’s
procedure [12], was approved by the three local research
ethics committees that reviewed the study.
Patients were not masked to their allocation as this is
clearly impossible to achieve with this type of intervention.
However, as a result of the randomisation procedure pa-
tients were unaware of other treatment allocations.
Interventions and comparators
Problem-solving therapy
This short-term therapy was delivered in the patient’s
home, after discharge, by one of two Community Psychi-
atric Nurses employed specifically for the study. The aim
was to improve the patient’s problem solving skills, so
that the patient feels he or she is taking control of cop-
ing. Improved coping skills should result in reduced psy-
chological distress and rates of depression. The therapist
followed a manual in helping the patient to identify and
prioritise problems, set goals and identify solutions to
the problems, choose and try a plausible solution and
then re-assess in the light of the results. The therapy
had six sessions: identifying stroke related problems in-
cluding gaps in knowledge about stroke; identifying non-
stroke problems; identifying available external resources;
identifying personal coping resources; looking at the
problem-solving process, and summarising the process.
The therapy has been described in more detail elsewhere
[13]. The six sessions were planned to be given in 6 h,
about a fortnight apart, with the patient doing ‘home-
work’ between each meeting. One benefit of a manual-
based therapy is that the therapist can give more or less
time to each session by monitoring the patient’s pro-
gress. The therapy was adaptable to be used with or
without a carer present. The therapists received training
and regular clinical supervision from a specialist liaison
psychiatrist (AH). The therapy was not given if the pa-
tient was discharged to residential care or remained in
hospital 6 months after stroke.
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Non-specific support
One of 47 volunteers recruited to the study was assigned
to provide talking (non-specific) support. The volunteers
attended a training meeting that focussed on the conse-
quences of stroke. More than half the volunteers had per-
sonal or family experience of stroke. We asked the
volunteer to visit the patient 6–8 times and paid travel
expenses. For practical reasons the volunteers began their
visits to the patient soon after randomisation, sometimes
before the patient was discharged.
Treatment as usual
No additional effort was made, during the course of the
trial, to enhance routine psychiatric care in stroke ser-
vices. At the time of the trial, no stroke service in Leeds
or Bradford had dedicated clinical psychology or psych-
iatry time available for the treatment of mood disorders
associated with stroke, although referral was possible
from all services for mental health assessment and treat-
ment of cases identified by stroke staff as requiring spe-
cialist care.
Outcome assessment
A trained interviewer obtained personal and social de-
tails, and undertook the following assessments during
the initial interview:
The Mini-Mental State Examination (MMSE) [11],
a brief screen for cognitive dysfunction. It is scored
0–30 with higher scores indicating better function.
The Barthel index [14], which assesses activities of
daily living skills. It is scored 0–20, with higher scores
indicating greater abilities. The patient’s self-reported
pre-stroke and post-stroke abilities were assessed.
The Frenchay Activities Index [15] is a measure of so-
cial function, scored 0–45, with higher scores indicating
greater function. It is broader in scope than the Barthel
index, including items to assess frequency of shopping,
travel, hobbies, etc. The patient’s self-reported pre-stroke
activities were assessed.
The Present State Examination: short form (PSE) [10]
is a semi-structured, standardised psychiatric interview
from which is derived an index of definition. The index
has a range 1–7, with a score of > 5 indicating probable
psychiatric disorder; we gave each of these cases a psy-
chiatric diagnosis according to the research criteria of
ICD-10.
The General Health Questionnaire (GHQ-28) [9] is
a measure of psychological distress scored 0–28, with
higher scores indicating greater distress. Scores on
the GHQ can be used to identify probable psychiatric
disorder: for neurological in-patients the threshold is
> 12 and among outpatients the threshold is > 9 and
above.
The patients also completed an adapted version of a
scale to assess satisfaction with aspects of care given in
hospital and after discharge [16].
Follow up assessments took place in the patient’s
home with an interviewer who was not informed of the
treatment allocation of the patient. Patients who re-
ceived problem-solving were asked by the therapist not
to reveal their allocation. To test the extent of unmask-
ing of outcome assessors, we asked the interviewer to
guess the allocation of 127 patients seen at 12 months.
Primary assessments were PSE and GHQ-28 at 12
months. Secondary assessments were: the Barthel index,
the Frenchay Activities Index, patient satisfaction, medi-
cation use, and contacts with health and social services
at 12 months, and all the above at 6 months.
Sample size calculation
The sample size of 450 was calculated to give 80% power
to detect a 2-point difference in GHQ score, including
an estimate of 20% lost to follow-up, through death and
refusals, randomly distributed between the groups. We
based the sample size calculation for the study on pro-
ducing a 2-point change because no minimally clinically
important difference has been defined for the GHQ
since it is designed primarily as a screening tool.
Statistical analysis
Prior to starting the study we planned to undertake two
forms of analysis: in the first (Phase 1) we planned to
compare the outcome data for all three groups at 6 &
12months to test variation between them. In the second
(Phase 2) we planned to compare problem-solving ther-
apy with the other 2 groups to test its benefit.
Our methods of analysis included the Kruskal-Wallis
(non-parametric) analysis of variance to examine ordinal
scales in Phase 1. Other measures were dichotomised
and analysed using logistic regression in Phase 2 of our
plan. We used therapy as the ‘baseline’ group, since we
planned the trial to compare it with both treatment-as-
usual and non-specific support, similar to that provided
in previous studies [17].
Results
Recruitment
We received notification of almost 1900 stroke admis-
sions over 23 months (see Fig. 1), of which 542
(28.5%) patients were eligible for inclusion. Of this
total 450 (83.0%) patients agreed to the baseline inter-
view and were randomised. Two patients were rando-
mised in error: one who had not suffered a stroke
and another who also suffered dementia. These pa-
tients were withdrawn. The random allocation re-
sulted in similar numbers and distribution of baseline
variables in the three groups (see Table 1). The three
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methods of assessing psychiatric disorder produced
similar rates: approximately one fifth of patients were
identified as having a mood disorder within 1 month
of stroke.
At the 12month interview we were able to interview
124/133 (93.2%) eligible patients in treatment as usual,
116/134 (86.6%) in problem-solving therapy, and 124/
131 (94.6%) in volunteer support (see Fig. 1).
Contact with intervention
Thirty patients randomised to problem-solving therapy
(19.9%) did not receive any therapy intervention. For the
majority (19) this was because they were unable to do so
(see Fig. 1), but 10 patients refused the intervention ei-
ther immediately after randomisation or after discharge
when the therapist phoned to make the first appoint-
ment and one was withdrawn. Remaining patients
Fig. 1 CONSORT Flow Diagram
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received between 1 and 10 sessions (median 5) during
the 4months after stroke. Twenty-three patients (15.4%)
randomised to support did not receive any volunteer
visits. The commonest reason was patient refusal, often
immediately after randomisation. Patients received be-
tween 1 and 42 volunteer contacts in the first 12 months
after stroke (median 6) and many volunteers maintained
patient contact beyond 6–8 visits and after we had
stopped paying their travel expenses.
Functional and psychological scores at 6 and 12months
Patients randomised to problem-solving therapy had
non-significantly lower Barthel and Frenchay scores
compared to the volunteer support and treatment as
usual groups at 6 months. At 12 months, patients in the
problem-solving group had lower GHQ scores, with a
median score 2 points lower than the treatment as usual
group and one point lower than the volunteer support
group. When GHQ scores were converted into caseness
scores this difference was no longer significant. There
was also evidence of differences between the three
groups in their Barthel or Frenchay scores similar to
those observed at 6 months. Patients in the problem-
solving group had lower scores but these differences
were non-significant. See Table 2.
Outcomes
The psychological scores were converted to caseness (a
PSE index of definition > 5; a GHQ score > 9 or a major
depression diagnosis) we found that the problem-solving
therapy group had lower levels of major depression and
fewer patients had an index of definition of 5 or above
Table 1 Baseline data for all patients and the three randomised groups
Baseline variable N (%) or Median (IQR) All patients Problem solving therapy Volunteer support Treatment as usual
Female 207 (46%) 66 (44%) 76 (51%) 65 (43%)
Age 72 (65–79) 71 (65–79) 72 (64–78) 74 (68–80)
Previous stroke 94 (21%) 36 (24%) 26 (18%) 32 (21%)
Home owner 249 (56%) 78 (52%) 86 (58%) 85 (57%)
Lived alone pre-stroke 175 (39%) 64 (43%) 52 (35%) 59 (39%)
No named carer 46 (10%) 17 (11%) 14 (9%) 15 (10%)
In any paid work (pre-stroke) 131 (29%) 36 (24%) 45 (30%) 50 (33%)
Initial hospital stay (days) 27 (12–60) 26 (13–64) 27 (12–71) 26 (15–55)
Pre-stroke Barthel < 20 132 (29%) 51 (34%) 43 (29%) 38 (25%)
Pre-stroke Frenchay 27 (21–34) 26 (11–33) 29 (22–34) 29 (20–34)
Post-stroke Barthel 15 (9–18) 14 (9–18) 14.5 (9–19) 15 (9–18)
MMSE score 26 (23–28) 26 (23–28) 26 (23–28) 26 (23–27)
GHQ-28 total score 5 (2–9) 6 (2–10) 5 (2–10) 5 (2–9)
GHQ-28 score≥ 12 85 (19%) 29 (19%) 27 (18%) 29 (20%)
PSE total symptom score 5 (2–9) 5 (3–9) 5 (2–8) 4 (2–7)
PSE Index of definition ≥5 102 (23%) 34 (23%) 35 (24%) 33 (22%)
Major depressive episode 100 (22%) 36 (24%) 34 (23%) 30 (20%)
Any depressive episode 145 (32%) 51 (34%) 51 (34%) 43 (29%)
Table 2 Functional and psychological scores at 6 and 12 months
Variable Scores at 6 months median (IQR) Problem solving therapy Volunteer support Treatment as usual
Barthel Index 17 (12–20) 18 (13–20) 18 (15–20)
Frenchay Activities Index 10 (3–20) 12 (3–23) 12 (5–23)
GHQ-28 score 4 (2–8) 4 (2–9) 5 (2–9)
PSE total symptom score 4 (2–8) 6 (2–9) 5.5 (2–10)
Variable Scores at 12 months median (IQR) Problem solving therapy Volunteer support Treatment as usual
Barthel Index 17 (12–20) 18 (13.5–20) 18 (14–20)
Frenchay Activites Index 9.5 (4–21) 12 (5–24) 14.5 (3.5–26)
GHQ-28 score 3 (1–6) 4 (1–8) 5 (2–8)
PSE total symptom score 4 (2–7) 5 (2–9) 5 (2–9)
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at both 6 and 12months. Odds ratios and 95% confi-
dence intervals were calculated but the differences did
not reach statistical significance.
There was some evidence of differences between the
three groups in satisfaction with hospital care, with pa-
tients randomised to treatment as usual being the least
satisfied. Patients randomised to problem-solving were
more satisfied than patients who received treatment as
usual with three aspects of care after discharge. Odds ra-
tios (95% CI) were calculated but only three items were
significantly different at 6 months: the hospital staff
attended to my needs; satisfaction with support to help
cope with feelings about stroke and satisfaction with
interest shown in worries and concerns of patient since
stroke. At 12 months only satisfaction with information
received about voluntary organisations was significantly
better in the problem-solving therapy group. See Tables 3
and 4.
More patients in the problem-solving group dropped
out of the study than the other two groups, mainly due
to a higher refusal rate. One possibility is that patients
who received less therapy, or who were doing less well
in therapy, were more likely to drop out. However, if we
assume that the 18 problem-solving patients who re-
fused 12month follow-up had the same GHQ scores as
the mean of followed-up patients in the treatment as
usual group, the mean GHQ score in the problem-
solving group would have been 4.6 rather than 4.5, with
no change in the statistical significance of our result.
The 17 items of the satisfaction scale showed only 1
significant difference across all 3 groups, which is con-
sistent with what would be expected in this number of
secondary analyses.
To test the extent of masking we asked the interviewer
to guess the allocation of the last 127 patients, after their
12 month interview. The interviewer guessed correctly
in 65 (51.2%) patients (kappa = 0.26, p < .001), suggesting
that some unmasking had occurred. Treatment as usual
was the most frequent guess.
Discussion
There is some evidence from our study that problem-
solving therapy can be effective in reducing emotional
disorder at 12 months after stroke though the benefits
observed are modest. The therapy group had lower
GHQ scores at 12 months; and were more satisfied with
aspects of their care related to psychological outcomes
at 6 months. There was no difference in activity scores;
indeed patients in the therapy group were the least ac-
tive of the 3 groups. It is disappointing that therapy had
no effect on social activity, but perhaps not surprising
given that our chosen measure for this outcome (the
Frenchay Activities Index) is heavily dependent on basic
physical abilities. We surmise that patients’ activities
were limited more by the disabling effects of their stroke
than by their inclination to be socially active.
We chose GHQ as our primary outcome because it is
one of the most widely used and validated question-
naires to assess mood and because it has been tested in
numerous populations including people with stroke [18].
When we analysed the data on the basis of presence of
psychiatric disorder, defined according to research inter-
view, the difference was no longer-significant. One possi-
bility is that the intervention helps milder emotional
disturbance but not more severe states. Another inter-
pretation is that our study was under-powered to show a
significant reduction in this more stringent test. It is also
possible that the continuation of volunteer visits beyond
the planned intervention period, something that oc-
curred in a number of cases in our study, diluted any
between-groups differences; for example explaining why
the lower GHQ scores observed in the therapy group at
6 months did not reach significance.
Unlike many studies of psychological therapy we did
not limit recruitment to patients with symptoms of
mood disorder. Instead we used a broad recruitment
strategy in order to test the effects of the intervention as
a preventive treatment. We also thought it unlikely that
a brief psychological treatment such as problem solving
would have a meaningful effect on patients with an
established mood disorder. We decided not to include
patients in residential care, who live in environments
where it can be difficult to be an active problem solver,
and where it would be difficult to deliver the interven-
tion effectively. We also excluded patients with levels of
cognitive ability, speech and use of English that would
make the delivery of a talking psychological therapy
problematic.
We acknowledge that our recruitment strategies limit
the generalisability of the results in a wider stroke popu-
lation but we feel this is justified because the application
of problem- solving therapy in practice would most
likely be targeted at the community dwelling stroke pa-
tient with the potential to regain some degree of inde-
pendence in daily living. If we assume that in routine
practice therapy might be offered to those we excluded
because they were in another trial, those who did not
live locally and those who refused randomisation, then a
total of 682/1487 (46%) stroke survivors might be suit-
able for such a brief therapy.
Overall the results of this trial are encouraging but
nevertheless we recognise that a number of limitations
need to be considered. Multiple item testing is a prob-
lem that affects the measurement of satisfaction and
quality of life measures. This study used a large number
of outcome measures thereby increasing the possibility
of chance findings. The primary outcome variable was
GHQ score and this was significantly different between
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Table 3 Psychology, activity and proportion expressing dissatisfaction at 6 months after stroke
Variable Problem solving
therapy n (%)
Volunteer support n
(%) OR (95% CI)
Treatment as usual n
(%) OR (95% CI)
GHQ score≥ 9, 28 / 126 (22) 33 / 127 (26) 37 / 126 (29)
1.2 (0.69, 2.2) 1.4 (0.82, 3.1)
PSE index of definition ≥5 23 / 126 (18) 31 / 128 (24) 34 / 124 (27)
1.4 (0.78, 2.6) 1.7 (0.93, 3.1)
Major depression 23 / 126 (18) 34 / 128 (27) 35 / 124 (28)
1.6 (0.89, 2.9) 1.8 (0.97, 3.2)
Any depression 37 / 126 (29) 42 / 128 (33) 47 / 124 (38)
1.2 (0.72, 2.1) 1.5 (0.87, 2.5)
I have been treated with kindness and respect by the hospital staff, number
dissatisfied
2 / 121 (2) 7 / 125 (6) 1 / 125 (0.8)
3.5 (0.72, 17) 0.48 (0.04, 5.4)
The hospital staff attended well to my personal needs, number dissatisfied 4 / 121 (3.3) 12 / 125 (10) 3 / 125 (2)
3.1 (0.97, 9.9) 0.72 (0.16, 3.3)
I felt able to talk to the hospital staff about any problems, number
dissatisfied
13 / 120 (11) 12 / 124 (10) 11 / 125 (9)
0.88 (0.38, 2.0) 0.79 (0.34, 1.8)
I received all the information I wanted about my stroke, number dissatisfied 25 / 121 (21) 30 / 125 (24) 21 / 125 (17)
1.2 (0.66, 2.2) 0.77 (0.41, 1.5)
The doctors have done everything they can to make me well again,
number dissatisfied
7 / 121 (6) 10 / 124 (8) 6 / 124 (5)
1.4 (0.52, 3.9) 0.83 (0.27, 2.5)
I am happy with the recovery I have made since my illness, number
dissatisfied
24 / 121 (20) 25 / 125 (20) 22 / 123 (18)
1.0 (0.54, 1.9) 0.88 (0.46, 1.7)
I am satisfied with the treatment the therapists (e.g. occupational, physio,
speech) have given me, number dissatisfied
13 / 121 (11) 14 / 125 (11) 17 / 124 (14)
1.0 (0.47, 2.3) 1.3 (0.61, 2.8)
I was given enough information about allowances & services, number
dissatisfied
17 / 114 (15) 18 / 123 (15) 25 / 120 (21)
0.98 (0.48, 2.0) 1.5 (0.76, 3.0)
Things were well prepared for my return home, number dissatisfied 13 / 114 (11) 18 / 123 (15) 15 / 121 (12)
1.3 (0.62, 2.9) 1.1 (0.50, 2.4)
I am satisfied with the hospital outpatient services, number dissatisfied 12 / 116 (10) 12 / 124 (10) 13 / 121 (11)
0.93 (0.40, 2.2) 1.0 (0.45, 2.4)
The ambulance service is good and reliable, number dissatisfied 10 / 115 (9) 6 / 122 (5) 9 / 119 (8)
0.54 (0.19, 1.5) 0.86 (0.34, 2.2)
I get enough support from meals on wheels, home help, etc, number
dissatisfied
12 / 112 (11) 10 / 124 (8) 14 / 121 (12)
0.73 (0.30, 1.8) 1.1 (0.48, 2.5)
I am satisfied with the service from my GP, number dissatisfied 10 / 116 (9) 13 / 125 (10) 9 / 121 (7)
1.2 (0.52, 2.9) 0.85 (0.33, 2.2)
I am satisfied with the support to help me cope with my feelings about the
stroke, number dissatisfied
9 / 115 (8) 18 / 124 (14) 27 / 120 (22)
2.0 (0.86, 4.6) 3.4 (1.5, 7.6)
I am satisfied with the interest shown in my worries and concerns since the
stroke, number dissatisfied
11 / 115 (10) 22 / 124 (17) 27 / 120 (22)
2.0 (0.94, 4.4) 2.7 (1.3, 5.8)
I was given enough information about voluntary organisations, number
dissatisfied
19 / 116 (16) 24 / 124 (19) 35 / 120 (29)
1.2 (0.63, 2.4) 2.1 (1.1, 3.9)
I am satisfied that my family were encouraged to be involved in my care,
number dissatisfied
9 / 112 (8) 6 / 120 (5) 8 / 119 (7)
0.60 (0.21, 1.7) 0.82 (0.31, 2.2)
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Table 4 Psychology, activity and proportion expressing dissatisfaction at 12 months after stroke
Variable Problem solving
therapy n (%)
Volunteer support n
(%) OR (95% CI)
Treatment as usual n
(%) OR (95% CI)
GHQ ≥9 17 / 116 (15) 26 / 124 (21) 28 / 123 (23)
1.5 (0.79, 3.0) 1.7 (0.88, 3.3)
PSE index of definition ≥5 22 / 115 (19) 31 / 124 (25) 30 / 124 (24)
1.4 (0.76, 2.6) 1.3 (0.72, 2.5)
Major depression 21 / 115 (18) 33 / 124 (27) 31 / 124 (25)
1.6 (0.88, 3.0) 1.5 (0.80, 2.8)
Any depression 32 / 115 (28) 38 / 124 (31) 38 / 124 (31)
1.1 (0.64, 1.9) 1.1 (0.63, 1.9)
I have been treated with kindness and respect by the hospital staff, number
dissatisfied
1 / 111 (0.9) 3 / 115 (3) 2 / 121 (2)
2.9 (0.30, 29) 1.8 (0.16, 21)
The hospital staff attended well to my personal needs, number dissatisfied 4 / 111 (4) 6 / 115 (5) 7 / 121 (6)
1.5 (0.40, 5.4) 1.6 (0.47, 5.8)
I felt able to talk to the hospital staff about any problems, number
dissatisfied
9 / 111 (8) 12 / 115 (10) 11 / 121 (9)
1.3 (0.53, 3.3) 1.1 (0.45, 2.8)
I received all the information I wanted about my stroke, number dissatisfied 13 / 111 (12) 24 / 115 (21) 20 / 121 (16)
2.0 (0.95, 4.1) 1.5 (0.70, 3.2)
The doctors have done everything they can to make me well again,
number dissatisfied
4 / 111 (4) 8 / 114 (7) 7 / 121 (6)
2.0 (0.59, 6.9) 1.6 (0.47, 5.8)
I am happy with the recovery I have made since my illness, number
dissatisfied
20 / 111 (18) 26 / 115 (23) 28 / 120 (23)
1.3 (0.69, 2.5) 1.4 (0.73, 2.6)
I am satisfied with the treatment the therapists (e.g. occupational, physio,
speech) have given me, number dissatisfied
13 / 111 (12) 9 / 115 (8) 13 / 120 (11)
0.64 (0.26, 1.6) 0.92 (0.40, 2.1)
I was given enough information about allowances & services, number
dissatisfied
12 / 107 (11) 21 / 112 (19) 17 / 119 (14)
1.8 (0.85, 3.9) 1.3 (0.60, 2.9)
Things were well prepared for my return home, number dissatisfied 9 / 107 (8) 18 / 111 (16) 17 / 118 (14)
2.1 (0.90, 4.9) 1.8 (0.78, 4.3)
I am satisfied with the hospital outpatient services, number dissatisfied 9 / 107 (8) 19 / 110 (17) 12 / 118 (10)
2.3 (0.98, 5.3) 1.2 (0.50, 3.0)
The ambulance service is good and reliable, number dissatisfied 7 / 108 (6) 6 / 106 (6) 5 / 118 (4)
0.87 (0.28, 2.7) 0.6 (0.20, 2.1)
I get enough support from meals on wheels, home help, etc, number
dissatisfied
6 / 106 (6) 17 / 107 (16) 12 / 118 (10)
3.1 (1.6, 8.3) 1.9 (0.68, 5.2)
I am satisfied with the service from my GP, number dissatisfied 7 / 107 (6) 17 / 111 (15) 12 / 117 (10)
2.6 (1.0, 6.5) 1.6 (0.62, 4.3)
I am satisfied with the support to help me cope with my feelings about the
stroke, number dissatisfied
14 / 108 (13) 17 / 111 (15) 19 / 118 (16)
1.2 (0.57, 2.6) 1.3 (0.61, 2.7)
I am satisfied with the interest shown in my worries and concerns since the
stroke, number dissatisfied
13 / 108 (12) 16 / 111 (14) 23 / 117 (20)
1.2 (0.56, 2.7) 1.8 (0.85, 3.7)
I was given enough information about voluntary organisations, number
dissatisfied
13 / 108 (12) 19 / 110 (17) 33 / 116 (28)
1.5 (0.71, 3.3) 2.9 (1.4, 3.7)
I am satisfied that my family were encouraged to be involved in my care,
number dissatisfied
7 / 107 (6) 10 / 108 (9) 11 / 116 (9)
1.5 (0.53, 4.0) 1.5 (0.56, 4.0)
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the three groups, but mood was also assessed by GHQ
caseness, total symptom score, PSE index of definition
and major depression, at both 6 & 12months after
stroke. However, it is important to note that all the sig-
nificant differences favoured the therapy group, includ-
ing a measure of satisfaction of many aspects of hospital
and community care.
We also acknowledge the effect of interviewer bias
and the extent of unmasking of the outcome inter-
viewers to the patient’s allocation but the influence of
this effect on the results should not be overstated given
that in almost 50% occasions the interviewer failed to
guess the patient’s allocation correctly. Furthermore, the
two significant measures: the GHQ and the satisfaction
scale, were self-report measures thus lessening the effect
of interviewer bias.
The impact of the volunteer visitors is harder to dis-
count as we did not control what they were doing in
their intervention. The results of a small diary and focus
group study suggest that there was considerable vari-
ation between the volunteers, and that the type of inter-
vention they provided was driven by their personal
experience of stroke.
Conclusion
Our trial randomised 150 patients to receive a short-
term psychological treatment and demonstrated that
problem-solving therapy has potential value for the re-
duction or prevention of emotional disorders after
stroke. Benefits of interventions have two components:
the specific effects of the treatment itself and the per-
ception that the therapy is being given. In this study, as
a placebo arm was not possible, we controlled for non-
specific effects using the volunteer support arm to which
a similar number of patients were randomised. Replica-
tion is needed to confirm our findings, preferably in
multi-centre trials with larger sample sizes, and incorp-
orating some form of process measure in an attempt to
gain a better understanding of how patients make use of
the therapy intervention.
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